The University of Texas Southwestern Medical Center
Locations
Transplant Summary
Overview
The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center is one of the nation's leading programs for hematologic malignancies. With a focus on excellence and compassion, our physicians and staff manage patients at all stages of their care. The program has an excellent track record in the delivery of state-of-the-art transplants. In addition, the program features an active translational research component that aims to improve transplant results by applying recent advances in immunobiology to the clinic.This center has been performing allogeneic transplants since 1999 and has been an NMDP transplant center since December 2001.
Attending physicians
Adult - Aimaz Afrough , Julio Alvarenga, Larry Anderson, Farrukh Awan, Stephen Chung, Robert Collins, Vivian Irizarry, Clayton Jackson, Gurbakhash Kaur, Adeel Khan, Yazan Madanat, Alejandro Marinos, Praveen Ramakrishnan, Heather Wolfe, Elif YilmazTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult onlyOther programs and services
As part of the only National Cancer Institute-designated Comprehensive Cancer Center in North Texas, The Hematologic Malignancies/Blood and Marrow Transplant Program at UT Southwestern Medical Center is able to offer referring physicians and patients a range of services unsurpassed in the region, including:
• Diagnosis and treatment of all hematologic malignancies
• Stem cell transplantation - autologous, allogeneic related and unrelated, cord blood, haploidentical)
• Investigational therapy
• Specialized center for acute myeloid leukemia and myelodysplastic syndrome, plasma cell neoplasms (multiple myeloma, Waldenstroms macroglobulinemia, and amyloidosis), chronic lymphocytic leukemia, and acute lymphoblastic leukemia
• Familial malignancies clinic
• Cutaneous T-cell lymphoma clinic
• CNS lymphoma clinic
• Chronic GVHD (graft-versus-host disease) clinic
• Survivorship clinic
• Comprehensive second opinion service
• Nationally renowned hematopathology (microscopy, flow cytometry, cytogenetics, molecular diagnostics)
• In-depth genetic and functional screening of patients with relapsed/refractory malignancies, allowing for individualized molecular-targeted therapyPatient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 98 patients.The actual 1-year survival of these patients is 71.4%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 65.9% and 82.5%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
223
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total Marrow1PBSC17Cord blood0Total18Marrow5PBSC37Cord blood0Total42Marrow6PBSC54Cord blood0Total60MarrowBoth marrow & PBSC 163PBSC—Cord blood—Total163MarrowBoth marrow & PBSC 223PBSC—Cord blood0Total223All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44845-641065+0Total18Unrelated 0-18019-44745-642465+11Total42Autologous 0-18219-443545-646665+60Total163Total 0-18219-445045-6410065+71Total223Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorChristen BennettPhone: (214) 645-2619NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
UT Southwestern medical Center
2201 Inwood Rd Dallas, TX 75390 Phone:214-645-HOPE For more information about this program: http://utsouthwestern.net (Opens in a new tab)Overview
follow-up of patients who underwent transplant for both transplant related and survivorship issues with help of all sub-specialties in Internal Medicine
Staff
Program Director:Dr. Robert Collins, MDProgram Coordinator:Brendy Scoggins, RNMedical Specialties in Program
Allergy/immunology, cardiology, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: anytime after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital